PALMA, Spain and SAN DIEGO, March 6, 2018 /PRNewswire/ —
Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, announced today the completion of its Phase II clinical trial of SNF472, its lead candidate for the…